Milestone Pharmaceuticals Statistics
Total Valuation
MIST has a market cap or net worth of $50.36 million. The enterprise value is $36.39 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, before market open.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MIST has 66.26 million shares outstanding. The number of shares has increased by 44.83% in one year.
Current Share Class | 53.35M |
Shares Outstanding | 66.26M |
Shares Change (YoY) | +44.83% |
Shares Change (QoQ) | +0.13% |
Owned by Insiders (%) | 0.53% |
Owned by Institutions (%) | 37.50% |
Float | 53.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.03 |
P/TBV Ratio | 3.90 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.10, with a Debt / Equity ratio of 4.17.
Current Ratio | 9.10 |
Quick Ratio | 8.79 |
Debt / Equity | 4.17 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11.76 |
Financial Efficiency
Return on equity (ROE) is -277.55% and return on invested capital (ROIC) is -38.56%.
Return on Equity (ROE) | -277.55% |
Return on Assets (ROA) | -34.92% |
Return on Invested Capital (ROIC) | -38.56% |
Return on Capital Employed (ROCE) | -62.49% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.26M |
Employee Count | 33 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.79% in the last 52 weeks. The beta is 1.38, so MIST's price volatility has been higher than the market average.
Beta (5Y) | 1.38 |
52-Week Price Change | -57.79% |
50-Day Moving Average | 1.94 |
200-Day Moving Average | 1.69 |
Relative Strength Index (RSI) | 29.21 |
Average Volume (20 Days) | 4,858,884 |
Short Selling Information
The latest short interest is 880,568, so 1.33% of the outstanding shares have been sold short.
Short Interest | 880,568 |
Short Previous Month | 742,790 |
Short % of Shares Out | 1.33% |
Short % of Float | 1.66% |
Short Ratio (days to cover) | 0.62 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -42.10M |
Pretax Income | -48.41M |
Net Income | -41.52M |
EBITDA | -42.00M |
EBIT | -42.10M |
Earnings Per Share (EPS) | -$0.67 |
Full Income Statement Balance Sheet
The company has $69.70 million in cash and $54.80 million in debt, giving a net cash position of $14.90 million or $0.22 per share.
Cash & Cash Equivalents | 69.70M |
Total Debt | 54.80M |
Net Cash | 14.90M |
Net Cash Per Share | $0.22 |
Equity (Book Value) | 13.15M |
Book Value Per Share | 0.20 |
Working Capital | 65.80M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$28.85 million and capital expenditures -$33,000, giving a free cash flow of -$28.88 million.
Operating Cash Flow | -28.85M |
Capital Expenditures | -33,000 |
Free Cash Flow | -28.88M |
FCF Per Share | -$0.44 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |